Hypoglycemic Agents in the Management of Type 2 Diabetes Mellitus

E-ISSN： 2212-3334|5|1|66-73

ISSN： 1872-2148

Source： Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol.5, Iss.1, 2011-01, pp. : 66-73

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GLP-1 as a Therapeutic Agent in Patients with Type 2 Diabetes Mellitus

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 1, Iss. 3, 2007-11 ,pp. : 193-201

Bentham Science Publishers

Access to resources Recommend Favorite

Biphasic (Premix) Insulin Analogs in Type 2 Diabetes Mellitus

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 2, Iss. 2, 2008-06 ,pp. : 129-134

Bentham Science Publishers

Access to resources Recommend Favorite

Diabetes Mellitus Type 2 and Functional Foods of Plant Origin

Recent Patents on Biotechnology, Vol. 8, Iss. 2, 2014-08 ,pp. : 160-164

Bentham Science Publishers

Access to resources Recommend Favorite

Management of Hyperglycemia in Gestational Diabetes Mellitus

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 2, Iss. 2, 2008-06 ,pp. : 123-128

Bentham Science Publishers

Access to resources Recommend Favorite

The Novel Use of GLP-1 Analogue and Insulin Combination in Type 2 Diabetes Mellitus

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 6, Iss. 2, 2012-05 ,pp. : 129-135

Bentham Science Publishers

Access to resources Recommend Favorite